J. Garcia Aymerich (Barcelona, Spain), A. Lindberg (Lulea, Sweden)
The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD
S. E. Budulac, D. S. Postma, P. S. Hiemstra, T. S. Lapperre, L. I. Z. Kunz, J. M. Vonk, M. H. Boezen, W. Timens (Groningen, Netherlands)
|  |
Association of airflow limitation with trauma exposure and posttraumatic stress disorder
B. Koch, C. Spitzer, H. J. Grabe, R. Ewert, S. Barnow, S. B. Felix, A. Obst, H. Völzke, S. Gläser, C. Schäper (Greifswald, Hamburg, Heidelberg, Germany)
|  |
COPD prevalence in Portugal. The Burden of Obstructive Lung Disease study (BOLD)
C. Bárbara, F. Rodrigues, H. Dias, J. Cardoso, J. Almeida, M. J. Matos, P. Simão, M. Santos, R. Ferreira, A. Gouveia, R. Hooper, A. Jithoo, P. Burney (Lisboa, Porto, , Coimbra, Portugal; London, United Kingdom)
| |
Prevalence of undiagnosed COPD in patients with established cardiovascular diseases
L. C. Loh, N. Selvarajah, S. Mohan, W. S. Choo, I. Omar (Georgetown, Malaysia)
| |
Studying the natural history of lung function in COPD patients in the 4-year UPLIFT® trial
D. Liu, B. Celli, M. Decramer, D. Tashkin, S. Kesten (Ridgefield, Boston, Los Angeles, United States Of America; Leuven, Belgium)
| |
Subjects with discordant airways obstruction: Lost between spirometric definitions of COPD
B. Lamprecht, L. Schirnhofer, B. Kaiser, S. Buist, M. Studnicka (Salzburg, Austria; Portland, United States Of America)
| |
Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
C. Lane, A. Wong, J. Burns, D. Sin, S. van Eeden (Vancouver, Canada)
| |
Exacerbation rates and healthcare costs following hospitalizations and emergency department visits for COPD
D. Mapel, M. Shah, A. D‘Souza, A. Dalal (Albuquerque, Palm Harbor, RTP, United States Of America)
| |
Frequency of hospitalizations due to COPD – Data from the Swedish Hospital Discharge Register
G. Engström, M. Gerhardsson de Verdier, E. Ståhl, C. G. Löfdahl, G. Tornling (Lund, Sweden)
| |
The Northjutland COPD follow-up prevention study (NCPS)
J. G. Hansen, L. Pedersen, K. Overvad, O. Omland, H. K. Jensen, H. T. Sørensen (Aalborg, Denmark)
| |
Increased relative mortality in women with severe oxygen-dependent COPD
M. Ekström, K. Franklin, K. Ström (Karlskrona, Sweden)
| |
Quality of life estimates for different diagnostic and socio-economic groups in Sheffield
A. Darby, J. Waterhouse, C. Billings, C. Billings, J. Wight, D. Fishwick (Harpur Hill, Buxton, Sheffield, United Kingdom)
| |
COPD eDiary compliance: Comparison of age, symptom score, duration in clinical trial and country of origin
D. Reed, C. Curry, S. Rocchio, V. Arnera (Boston, United States Of America)
| |
Duration, intensity, and frequency of regular physical activity in COPD patients across severity stages
D. Donaire-Gonzalez, E. Rodriguez, J. de Batlle, J. Gea, E. Balcells, J. M. Antó, J. Garcia-Aymerich (Barcelona, Bunyola, Spain)
| |
In-flight respiratory symptoms and pre-flight characteristics in COPD patients
A. Edvardsen, A. Akerø, T. M. L. Eagan, M. Ryg, J. A. Hardie, P. Bakke, O. H. Skjønsberg (Hakadal, , Bergen, Norway)
| |
Does the cardiologist play a role in the diagnosis of COPD? Preliminary results from the SCOP-cardio study
R. Escamilla, V. Bongard, D. Taraszkiewicz, D. Brouquières, E. Bérard, N. Roche, T. Perez, S. Fiévez, F. Deschamps, J. Ferrières (Toulouse, Paris, Lille, France)
| |
Clinical effectiveness of triple therapy in the management of COPD: A systematic review
K. Gaebel, G. Blackhouse, D. Robertson, F. Xie, N. Assasi, A. McIvor, P. Hernandez, R. Goeree (Hamilton, Halifax, Canada)
| |